Interpretability of cancer clinical trial results using restricted mean survival time as an alternative to the hazard ratio.

Media Contacts

Lisa Jacobs
Communications Lead
Lisa.Jacobs@area-d.hcqis.org
720-554-1471


Lyndsay Fluharty
Communications Lead
Lyndsay.Fluharty@area-d.hcqis.org
720-554-1459

Newsletter Sign Up